Breaking News Instant updates and real-time market news.

DXCM

DexCom

$119.89

-1.34 (-1.11%)

08:02
11/21/18
11/21
08:02
11/21/18
08:02

Amended Verily agreement a win for DexCom, says William Blair

William Blair analyst Margaret Kaczor views the amendment to its collaboration agreement with Verily as a financial and strategic win for DexCom. The new deal should strengthen their partnership and "meaningfully improve" Dexcom's future profitability, Kaczor tells investors in a research note. Overall, despite the near-term dilution, the amended agreement is a positive step for the company that should give it more control over the launch prospects of its next-generation devices and flexibility over commercial strategies in the type 2 patient population, says the analyst. She keeps an Outperform rating on shares of DexCom.

  • 27

    Nov

  • 04

    Dec

DXCM DexCom
$119.89

-1.34 (-1.11%)

11/07/18
SPHN
11/07/18
NO CHANGE
Target $170
SPHN
Overweight
DexCom price target raised to $170 from $160 at Stephens
Stephens analyst Chris Cooley raised his price target on DexCom shares to $170 from $160 following the company's Q3 report and revenue guidance increase. He sees DexCom being well positioned to continued posting organic growth "in the top echelon of med tech" while realizing operating leverage. Cooley maintains an Overweight rating on DexCom shares.
11/07/18
JEFF
11/07/18
NO CHANGE
Target $148
JEFF
Buy
DexCom price target raised to $148 from $125 at Jefferies
Jefferies analyst Raj Denhoy raised his price target for DexCom (DXCM) to $148 saying the company posted "strong" Q3 results. Improving market access from pharmacy benefit is driving patient adds and helping blunt any advantage for Abbott's (ABT) Libre, says the analyst. He keeps a Buy rating on DexCom citing strong G6 adoption, new patients accelerating and still underpenetrated markets.
11/12/18
PIPR
11/12/18
NO CHANGE
PIPR
Piper continues to like pure play diabetes stocks after conference
Piper Jaffray analyst JP McKim left this weekend's Diabetes Technology Meeting feeling that DexCom (DXCM) "has a lot in its pipeline" and remains a few steps ahead of the competition, Insulet (PODD) is having "great success" in the pharmacy and is on the forefront of cybersecurity, and Tandem Diabetes (TNDM) remains in a "strong position to take market share." The analyst continues to like pure play diabetes names and keeps an Overweight rating on all three names.
11/21/18
PIPR
11/21/18
NO CHANGE
Target $157
PIPR
Overweight
Amended Verily agreement 'major win' for DexCom holders, says Piper Jaffray
After talking with management, Piper Jaffray analyst JP McKim believes the amended collaboration and license agreement with Alphabet's (GOOG, GOOGL) Verily "seems like a no brainer" and is a "major win for the long term value" of DexCom (DXCM) shareholders. The royalty payments from the original agreement have been eliminated and those would have been at least a 500 basis point headwind on the margin profile of DexCom's business, McKim tells investors in a research note. He expects the company to release some longer term margin targets at its analyst day and says "removing this future headwind is a major win." Further, DexCom is now the preferred continuous glucose monitoring supplier into Onduo's Type 2 diabetes management program, says the analyst. He reiterates an Overweight rating on the shares with a $157 price target.

TODAY'S FREE FLY STORIES

IAC

IAC

$177.17

1.91 (1.09%)

16:39
12/18/18
12/18
16:39
12/18/18
16:39
Initiation
IAC initiated  »

IAC initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$33.73

0.31 (0.93%)

16:37
12/18/18
12/18
16:37
12/18/18
16:37
Hot Stocks
Twitter initiates IOS update giving timeline feed chronological order feature »

Twitter added a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMD

TORM A/S

$7.15

(0.00%)

16:37
12/18/18
12/18
16:37
12/18/18
16:37
Syndicate
Breaking Syndicate news story on TORM A/S »

TORM A/S files $250M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$98.74

-3.03 (-2.98%)

16:37
12/18/18
12/18
16:37
12/18/18
16:37
Syndicate
Breaking Syndicate news story on Sage Therapeutics »

Sage Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 19

    Mar

OSUR

OraSure

$11.35

-0.17 (-1.48%)

16:36
12/18/18
12/18
16:36
12/18/18
16:36
Syndicate
Breaking Syndicate news story on OraSure »

OraSure files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

ADX

Adams Express

$12.81

-0.03 (-0.23%)

16:35
12/18/18
12/18
16:35
12/18/18
16:35
Hot Stocks
Adams Diversified Equity Fund authorizes repurchase of up to 5% of common stock »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil

$22.21

0.65 (3.01%)

16:35
12/18/18
12/18
16:35
12/18/18
16:35
Hot Stocks
Jabil up 11% after Q1 results beat estimates, strong Q2 revenue guidance »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

JCS

Communications Systems

$2.30

-0.025 (-1.08%)

16:33
12/18/18
12/18
16:33
12/18/18
16:33
Hot Stocks
Communications Systems initiates restructure »

Communications Systems,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$43.21

-0.38 (-0.87%)

16:32
12/18/18
12/18
16:32
12/18/18
16:32
Hot Stocks
Sanofi to transfer listing to Nasdaq from NYSE »

Sanofi announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

GNK

Genco Shipping

$7.90

0.06 (0.77%)

16:32
12/18/18
12/18
16:32
12/18/18
16:32
Hot Stocks
Genco Shipping names Robert Hughes as new COO effective January 22nd »

Genco Shipping &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$28.56

-0.46 (-1.59%)

16:32
12/18/18
12/18
16:32
12/18/18
16:32
Hot Stocks
Conagra Brands to divest the Wesson oil brand »

Conagra Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

JBGS

JBG Smith Properties

$36.42

0.05 (0.14%)

16:31
12/18/18
12/18
16:31
12/18/18
16:31
Hot Stocks
JBG Smith Properties declares special cash dividend of 10c per share »

JBG Smith announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLL

L3 Technologies

$184.11

-4.02 (-2.14%)

16:31
12/18/18
12/18
16:31
12/18/18
16:31
Hot Stocks
L3 Technologies awarded $350M U.S. Air Force contract »

L3 Technologies has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$8.11

-0.67 (-7.63%)

16:31
12/18/18
12/18
16:31
12/18/18
16:31
Hot Stocks
Adamas announces issuance of new U.S. patent covering GOCOVRI »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURF

Surface Oncology

$7.35

-0.44 (-5.65%)

16:30
12/18/18
12/18
16:30
12/18/18
16:30
Hot Stocks
Breaking Hot Stocks news story on Surface Oncology »

Surface Oncology Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
12/18/18
12/18
16:30
12/18/18
16:30
Options
Preliminary option volume of 21.5M today »

Preliminary option volume…

UPS

UPS

$97.25

0.33 (0.34%)

, FDX

FedEx

$185.01

2.81 (1.54%)

16:28
12/18/18
12/18
16:28
12/18/18
16:28
Hot Stocks
FedEx falls after FY19 guidance cut to $15.50-$16.50 from $17.20-$17.80 »

Shares of FedEx (FDX) are…

UPS

UPS

$97.25

0.33 (0.34%)

FDX

FedEx

$185.01

2.81 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ALKS

Alkermes

$31.83

-1.125 (-3.41%)

16:27
12/18/18
12/18
16:27
12/18/18
16:27
Downgrade
Goldman downgrades Alkermes to Sell ahead of potential schizophrenia launch »

Goldman Sachs analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 31

    Jan

CBS

CBS

$46.21

-0.6 (-1.28%)

, ORCL

Oracle

$45.82

0.1 (0.22%)

16:27
12/18/18
12/18
16:27
12/18/18
16:27
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks opened sharply…

CBS

CBS

$46.21

-0.6 (-1.28%)

ORCL

Oracle

$45.82

0.1 (0.22%)

JNJ

Johnson & Johnson

$130.38

1.27 (0.98%)

BA

Boeing

$328.26

11.88 (3.76%)

QCOM

Qualcomm

$57.77

0.78 (1.37%)

AAPL

Apple

$165.81

1.76 (1.07%)

TLRY

Tilray

$76.77

10.88 (16.51%)

NVS

Novartis

$85.40

-0.4 (-0.47%)

NAV

Navistar

$27.59

3.75 (15.73%)

APHA

Aphria

$5.86

0.42 (7.72%)

RCII

Rent-A-Center

$13.02

-1.43 (-9.90%)

LXFR

Luxfer

$18.76

-2.66 (-12.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 20

    Dec

  • 05

    Jan

  • 27

    Jan

LLY

Eli Lilly

$106.56

-1.8 (-1.66%)

, ADRO

Aduro Biotech

$2.49

-0.14 (-5.32%)

16:23
12/18/18
12/18
16:23
12/18/18
16:23
Hot Stocks
Eli Lilly, Aduro announce research collaboration for immunotherapy development »

Eli Lilly (LLY) and Aduro…

LLY

Eli Lilly

$106.56

-1.8 (-1.66%)

ADRO

Aduro Biotech

$2.49

-0.14 (-5.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

MDU

MDU Resources

$24.80

-0.39 (-1.55%)

16:22
12/18/18
12/18
16:22
12/18/18
16:22
Hot Stocks
MDU Resources reports record November backlog of $1.6B »

MDU Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$143.64

3.33 (2.37%)

, TWTR

Twitter

$33.73

0.31 (0.93%)

16:22
12/18/18
12/18
16:22
12/18/18
16:22
Hot Stocks
Trump claims Facebook, Twitter, Google 'so biased' towards Democrats »

U.S. President Donald…

FB

Facebook

$143.64

3.33 (2.37%)

TWTR

Twitter

$33.73

0.31 (0.93%)

GOOG

Alphabet

$1,028.79

11.19 (1.10%)

GOOGL

Alphabet Class A

$1,043.31

16.77 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

WIN

Windstream

$2.69

0.15 (5.91%)

16:21
12/18/18
12/18
16:21
12/18/18
16:21
Hot Stocks
Windstream sells fiber assets to Arvig in $49.5M cash deal, to sell $11M more »

Windstream announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$6.68

-0.43 (-6.05%)

16:20
12/18/18
12/18
16:20
12/18/18
16:20
Hot Stocks
McDermott signs a lease for new headquarters »

McDermott International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/18/18
12/18
16:20
12/18/18
16:20
Options
Closing CBOE SPX and VIX Index summary for December 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.